• offer an appraisal of all relevant literature up to April 2018, focusing on any key developments
• address important, practical clinical questions relating to the primary guideline objective and
• provide guideline recommendations and if appropriate research recommendations.
The guideline is presented as a detailed review with highlighted recommendations for practical use in primary care and in the clinic, in addition to an updated patient information leaflet [available on the British Association of Dermatologists (BAD) website, www.bad.org.uk/leaflets].
- systematic review
- 5-aminolaevulinic acid
- methyl aminolaevulinate
- non-melanoma skin cancer
- protoporphyrin IX
- topical photodynamic therapy